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Abstract
AIM: To review all cases of abdominal tuberculosis 
(ATB) for demographic details, diagnostic work up and 
evidence of vitamin D deficiency.
METHODS: This was a retrospective analysis of all 
patients diagnosed with ATB from June 2003 to August 
2013 at St George’s Hospital, London. Demographic 
data was available from the local tuberculosis database. 
Further clinical information was collected from elec-
tronic patient records, including radiology, endoscopy, 
microbiology, histology, biochemistry and serology. 
Patients were classified as either confirmed ATB [if 
mycobacteria tuberculosis (MTB) was cultured from 
abdominal site] or presumed ATB (if suggestive 
findings or high clinical suspicion). Subtypes of ATB 
were classified as tuberculosis (TB) peritonitis, luminal 
TB, solid organ TB or from a combination of sites.
RESULTS: There were a total of 65 cases identified 
in this time period, with a mean of 6.5 cases per year 
(range 4-9). Mean age 42 years, 49.2% females. 
Fifty-two point three percent were South Asian, 
38.5% African. Forty-nine point two percent had 
gastrointestinal endoscopy, 30.8% paracentesis and 
24.6% surgery in order to obtain samples. Forty-seven 
point seven percent were defined as confirmed ATB 
with positive culture of MTB from abdominal sites, the 
rest were treated as presumed ATB. Twenty-four point 
six percent had co-existing sputum culture positive 
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for MTB, and 30.8% had an abnormal chest X-ray. 
Subtypes of ATB: 35.4% had TB peritonitis; 27.7% 
luminal TB; 3.1% solid organ TB; and 33.8% TB at a 
combination of abdominal sites. Thirteen point nine 
percent were human immunodeficiency virus positive, 
all with CD4 count less than 300 cells/μL. Seventy point 
five percent had severe vitamin D deficiency, and 25% 
were vitamin D deficient.
CONCLUSION: ATB mainly affects young South Asian 
and African patients, with difficulties in confirming 
diagnosis despite a range of non-invasive and invasive 
diagnostic tests.
Key words: Abdominal; Gastrointestinal; Tuberculosis; 
vitamin D; Human immunodeficiency virus
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: This is a single centre retrospective study 
of all cases of abdominal tuberculosis (ATB) from a 
single centre in the developed world. ATB remains a 
rare condition in the United Kingdom, which mainly 
occurs in young South Asians and African patients, 
and remains difficult to diagnose. When suspected, 
endoscopic biopsies must be taken in normal saline 
for microbiological assessment to help confirm the 
diagnosis. Chest radiology and sputum analysis 
should be performed as nearly a quarter had co-
existent pulmonary tuberculosis. vitamin D deficiency 
is common, and often severe, in ATB. Patients with 
human immunodeficiency virus and ATB present with 
low CD4 counts.
Nayagam JS, Mullender C, Cosgrove C, Poullis A. Abdominal 
tuberculosis: Diagnosis and demographics, a 10-year 
retrospective review from a single centre. World J Clin Cases 
2016; 4(8): 207-212  Available from: URL: http://www.
wjgnet.com/2307-8960/full/v4/i8/207.htm  DOI: http://dx.doi.
org/10.12998/wjcc.v4.i8.207
INTRODUCTION
Abdominal tuberculosis (ATB) is a rare form of extra-
pulmonary tuberculosis which can prove to be clinically 
challenging. It remains difficult to diagnose due to 
the non-specific presentation, variable anatomical 
location and lack of sensitive diagnostic tools[1]. ATB 
may occur anywhere within the abdomen, involving the 
gastrointestinal tract, visceral organs or peritoneum. 
There can be difficulty differentiating ATB from Crohn’s 
disease clinically, endoscopically and histologically[2,3]. 
Both diseases have a predilection for the small bowel, 
and cause chronic granulomatous inflammation[4]. 
There are significant clinical implications of incorrectly 
diagnosing tuberculosis (TB) and committing patients to 
a prolonged course of toxic chemotherapy; or missing 
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TB with public health implications and causing life-
threatening disseminated TB if immunosuppressant 
therapy is erroneously initiated.
Although TB rates in the United Kingdom have 
plateaued in recent years, there is still a high preva-
lence in the non-United Kingdom born population, 
predominantly in urban areas[5]. The number of extra-
pulmonary cases, including ATB, is increasing with 
figures in England and Wales rising from 175 cases of 
gastro-intestinal TB in 1999, to 315 cases in 2006[6]. 
This increase is largely attributable to an increase in the 
number of non-United Kingdom-born cases, in whom 
extra-pulmonary TB is much more common. In London, 
5% of all cases of TB were ATB in 2012[7].
There has been an emergence of a role for vitamin 
D beyond bone health, as an immune regulator[8]. 
Supplementation of vitamin D is now routine practice in 
the treatment of pulmonary TB (PTB), although clinical 
data is not conclusive and there may only be a clinical 
benefit in a subgroup of patients[9-11]. The association 
between inflammatory bowel disease (IBD) and vitamin 
D deficiency is well recognised[12] and has become of 
great interest. Animal models suggest that mice with 
vitamin D deficiency suffer from more severe colitis, 
potentially due to compromised mucosal barrier[13]. 
The role of vitamin D deficiency in ATB has yet to be 
investigated.
We report a retrospective study of all cases of ATB 
from an urban area, with a large migrant population, 
over a 10-year period. The objectives of this study were 
to: (1) describe the demographic profile of patients 
with ATB; (2) review the use of diagnostic modalities, 
both non-invasive and invasive, and the certainty of 
diagnosis of ATB; and (3) report vitamin D status of 
patients diagnosed with ATB.
MATERIALS AND METHODS
Patient selection
We performed a retrospective review of patients treated 
for ATB at St George’s Hospital, London, from June 2003 
to August 2013. Cases were identified from a local TB 
database, which encompasses all patients who have 
received treatment for TB at St George’s Hospital. 
Patients from this database were included in our study 
if they were reported as having TB involvement at an 
abdominal site. Cases were excluded if they were not 
investigated at St George’s Hospital, or if there was no 
evidence of involvement at an abdominal site.
Clinical information
Demographic data was available from the TB database. 
Further information on clinical investigations was 
collected from the electronic patient records: Radiology 
[including chest radiograph, ultrasound, computed 
tomography (CT), magnetic resonance imaging (MRI), 
small bowel series], endoscopy, methods by which 
samples were obtained, microbiology, histology, vitamin 
D level and human immunodeficiency virus (HIV) status.
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Definitions
Ethnicity was defined as European, South Asian (Indian, 
Pakistani, Bangladeshi, Sri Lankan, any other Asian 
background), African, and Caribbean.
The reference range for vitamin D at our hospital is 
from 75-200 nmol/L. Vitamin D levels were classified 
as deficient (25-50 nmol/L) or severe deficiency (< 
25 nmol/L). Vitamin D analysis was carried out using 
the immunodiagnostic systems total 25 OH vitamin 
D2 and D3 (25 hydroxy-vitamin D) assay according to 
manufacturer’s instruction.
In defining the accuracy of diagnosis of ATB we sub-
grouped into: (1) confirmed ATB if mycobacterium 
tuberculosis (MTB) was cultured from an abdominal 
site; and (2) presumed ATB if there was suggestive 
histology, suggestive history, suggestive imaging. MTB 
was isolated from an extra-abdominal site, or if there 
was high clinical suspicion.
TB peritonitis was defined as ascites, peritoneal 
thickening or intra-abdominal lymph nodes; luminal TB 
was defined as TB from the oesophagus to the anus, 
including perianal disease; solid organ TB was hepatic 
or biliary involvement; combination of sites was when 
TB was isolated from one site, but imaging suggested 
concurrent involvement at other sites.
Statistical analysis
Due to small sub-group numbers comparative statistical 
analysis was not carried out. 
Ethics approval
Ethics committee approval was not required (as a re-
trospective analysis of a previously investigated clinical 
cohort) according to the United Kingdom National 
Research Ethics Service[14].
RESULTS
Number of cases
A total of 65 adults were treated at St George’s Hospital 
for ATB from June 2003 to August 2013. By our case 
definition, 31 (47.7%) were confirmed ATB, and 34 
(52.3%) were presumed ATB. The number of cases 
of ATB over the 10-year period has remained stable, 
with a mean of 6.5 cases per year (range 4-9), which is 
demonstrated in Figure 1.
Demographics
The mean age was 42 years (range 16-97 years). There 
were 32 females (49.2%) and 33 males (50.8%). Age 
and ethnicity split is shown in Table 1.
Radiology
Sixty-four (98.5%) were screened for pulmonary TB 
with a chest x-ray, with 20 (30.8% of total) reported as 
abnormal (Table 2).
Prior to diagnosis with ATB patients underwent the 
following abdominal imaging modalities: 42 (64.6%) 
ultrasound, 46 (70.8%) CT, 2 (3.1%) MRI, and 7 
(10.8%) barium small bowel series. The main findings 
of these are shown in Table 3.
Endoscopy
Prior to diagnosis 32 (49.2%) underwent gastrointes-
tinal endoscopy (GIE): 18 had upper GIE; 21 lower GIE; 
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Figure 1  Number of cases of abdominal tuberculosis by year of the study.
Table 1  Age and ethnicity of patients with abdominal 
tuberculosis
Number Mean age Median age
South Asian 34 (52.3%)    42.3    39.5
African 25 (38.5%)    36.1 35
European 5 (7.7%)    72.4 69
Caribbean 1 (1.5%) 28 28
Table 2  Chest radiograph findings n  (%)
Findings Number of patients (n  = 64)
Normal 44 (68.9)
Consolidation 11 (17.2)
Pleural effusion 3 (4.7)
Lymphadenopathy (para-tracheal, hilar) 6 (9.4)
Apical scarring 1 (1.6)
Nodularity 5 (7.8)
Focal lesion 1 (1.6)
Pleural thickening 1 (1.6)
Multiple radiographic features   7 (10.9)
Mention of tuberculosis in differential 6 (9.4)
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and 7 both upper and lower GIE (Table 4).
Methods of obtaining samples
The main invasive modality undertaken to obtain samples 
was endoscopy in 49.2% of subjects, paracentesis 
was carried out in 30.8% and surgery in 24.6%, other 
samples were acquired under radiological guidance, 
from swabs and from peritoneal dialysis fluid. The 
majority of specimens were sent for histology, however 
there was variability in numbers sent for microbiology, 
with endoscopic specimens being sent less frequently, 
and also having a lower yield (Table 5).
Microbiology
MTB was cultured from abdominal sites in 31 (47.7%) 
patients. Of those with culture positive ATB, 30 (96.8%) 
patients had fully sensitive organisms, 1 (3.2%) patient 
had an organism resistant to isoniazid and streptomycin.
Forty-four (67.7%) had sputum samples sent for 
AFB testing and TB culture, with 16 (24.6% of total) 
obtaining positive cultures for MTB. Of the positive 
MTB sputum cultures, 15 patients (93.8%) were fully 
sensitive and 1 (6.3%) resistant to pyrazinamide.
The site of positive cultures was 7 (11%) isolated TB 
from abdominal and pulmonary specimens, 24 (37%) 
cultured from abdominal specimens alone, 9 (14%) 
cultured from pulmonary specimens alone, and 25 
(38%) with no positive culture.
Site of ATB
The sites are shown in Figure 2: TB peritonitis in 23 
(35.4%), luminal TB in 18 (27.7%), solid organ TB in 2 
(3.1%), combination of sites in 22 (33.8%).
HIV
Fifty (77%) of the patients were tested for HIV, and 9 
(13.9%) were HIV positive. All HIV positive patients 
were non-Europeans (1 South Asian, 8 Africans). Five 
were diagnosed with ATB within 1 year of their HIV 
diagnosis. All had low CD4 counts (below 300 cells/μL), 
7 (77.8%) had a CD4 count of less than 200 cells/μL, 
4 had been started on antiretrovirals prior to diagnosis 
and had undetectable viral load.
Vitamin D
Vitamin D levels were measured within 1 year of 
diagnosis (mean 1.4 mo, median 1 mo, range 0-8 
mo) in 44 patients (67.7%), with a mean of 23 nmol/L 
(range undetectable-102 nmol/L). Of those who had 
measurements, 31 (70.5%) had severe deficiency (< 
25 nmol/L), 11 (25%) were deficient (25-50 nmol/L).
DISCUSSION
In this study, we have reported a large modern urban 
case series of ATB in the developed world, where the 
number of cases per year has remained stable. It has 
TB peritonitis and luminal 
TB
TB peritonitis and solid 
organ TB
TB peritonitis, luminal TB 
and solid organ TB
Figure 2  Breakdown of sites of abdominal tuberculosis involvement 
where combination of sites. TB: Tuberculosis.
Table 3  Ultrasound and computed tomography findings prior 
to diagnosis with abdominal tuberculosis n  (%)
Ultrasound findings (n = 42)
   Mention of TB as differential 3 (7.1)
   Normal 16 (38.1)
   Ascites 16 (38.1)
   Intra-abdominal lymphadenopathy   6 (14.3)
   Bowel thickening   7 (16.7)
   Abdominal collection 1 (2.4)
   2 ultrasound findings1 4 (9.5)
CT findings (n = 46)
   Mention of TB as differential 22 (47.8)
   Normal 3 (6.5)
   Ascites 20 (43.5)
   Intra-abdominal lymphadenopathy 25 (54.3)
   Bowel thickening 27 (58.7)
   Peritoneal thickening   9 (19.6)
   1 CT finding2 17 (37.0)
   2 CT findings 15 (32.6)
   3 or more CT findings 11 (23.9)
1Four cases of intra-abdominal lymphadenopathy and bowel thickening; 
2Three had only ascites, 7 only intra-abdominal lymphadenopathy, 6 only 
bowel thickening, 1 only peritoneal thickening. TB: Tuberculosis; CT: 
Computed tomography.
Table 4  Endoscopic findings prior to diagnosis with 
abdominal tuberculosis n  (%)
Upper GI endoscopy findings (n = 18)
   Normal 10 (55.5)
   Oesophageal ulcers   3 (16.7)
   Gastritis 1 (5.6)
   Gastric ulcer 1 (5.6)
   Duodenitis   3 (16.7)
   Duodenal scalloping 1 (5.6)
   2 endoscopic findings1 1 (5.6)
Lower GI endoscopy findings (n = 21)
   Normal   4 (19.0)
   Colonic inflammation 11 (52.4)
   Ileocolonic ulcers   5 (23.8)
   Ileocolonic nodularity 1 (4.8)
   Colonic stricture 2 (9.5)
   Colonic polyps 2 (9.5)
   2 endoscopic findings2   4 (19.0)
1Oesophageal ulcer and gastritis; 2Tow had colonic inflammation and 
ulcers, 2 had colonic inflammation and an inflammatory colonic stricture. 
GI: Gastrointestinal.
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mainly been detected in young minority ethnic groups, 
with a small group of elderly Europeans. As part of 
their diagnostic work up they have undergone multiple 
investigations, and despite this the confirmation by 
MTB culture occurs in less than half of cases. Nearly a 
quarter of patients had co-existent active pulmonary 
tuberculosis. Vitamin D deficiency is common and often 
severe in patients with ATB, and includes the whole 
range of demographics and phenotypes of disease.
The majority of patients were South Asian, however 
there was a significant cohort of African origin. Previous 
studies in United Kingdom investigating ATB, from 
Leicester[15], Blackburn[16] and Bradford[17] have shown 
the majority of ATB occurring in South Asians, and in 
London particularly in the Bangladeshi population[18]. 
Our series demonstrates a sizeable young African 
population with ATB in London, a demographic not 
previously reported.
Confirming a diagnosis of abdominal TB is noto-
riously difficult, with the rate of positive culture from 
abdominal sites below 50% in our series, which is similar 
to previously reported rates in the United Kingdom[17]. 
Non-invasive imaging is useful to characterise the 
phenotype of abdominal TB and suggest sites for 
sampling, however it does not assist in obtaining a 
definitive diagnosis, with sampling for microbiological 
confirmation the gold standard for diagnosis. Only 
61.8% of samples acquired from invasive procedures 
(paracentesis, endoscopy, surgery) were sent for 
micobiological assessment. In our series ascitic fluid and 
surgically acquired biopsies had a highest diagnostic 
yield. There was low rate of endoscopic biopsies being 
sent for microbiological assessment. If TB is part of 
the differential diagnosis then endoscopists must 
ensure microbiological samples are routinely taken 
into normal saline solution rather than the standard 
formalin histopathology pots and sent for MTB culture[1]. 
The identification of resistant strains highlights the 
importance of appropriate sampling and microbiological 
analysis. Despite this, if ATB is suspected then empirical 
treatment is warranted[5], as even with extensive 
interventions it is not always possible to obtain positive 
cultures.
The clinical implications of vitamin D deficiency, 
and replacement in ATB, is yet to be reported. In the 
absence of this, data can be extrapolated from vitamin D 
deficiency linked with pulmonary TB[19] and inflammatory 
bowel disease[20], both conditions which have clinical 
and pathological similarities to ATB. Of particular interest 
is whether, as suggested in animal models, there is 
a compromised colonic mucosal barrier with vitamin 
D deficiency[13], which could exacerbate luminal and 
peritoneal TB in particular. Further work needs to be 
carried out to identify if vitamin D deficiency play a 
pathological role in abdominal TB and if supplementation 
improves treatment outcomes, however in the interim, 
testing and treatment of any deficiency appears to be 
advisable.
There are limitations to our study. The first being 
the retrospective design which is subject to recall bias 
and confounding variables, as the data set was not 
specifically designed for research purposes. However, 
our data was collected from interrogation of clinical 
and electronic records making this less likely and the 
variables studied (vitamin D, demographics and HIV) 
have independently been described as important 
factors in TB[19,21]. The second limitation is based on the 
definition of vitamin D deficiency which despite multiple 
studies has no robust classification and therefore the 
accepted ranges of vitamin D deficiency are variable. 
Also the vitamin D levels taken for our patients were not 
always from the time of diagnosis, and hence could be 
subject to other factors, such as the effect of treatment. 
Due to the small numbers in each sub-group (for sites, 
ethnicity, vitamin D levels and HIV status) comparative 
statistics was not possible, larger studies are needed to 
explore these findings further. Unfortunately, the time 
that different ethnic groups had been resident in the 
United Kingdom was unknown. 
In summary, this large retrospective series re-
minds us that ATB is still a diagnosis to consider in 
individuals presenting with abdominal symptoms in the 
developed world, particularly in patients from ethnic 
minorities. Diagnosis can be challenging and requires 
a multidisciplinary approach with involvement from 
Radiology, Microbiology, Gastroenterology, Surgery, 
Infectious Diseases and Respiratory teams. An increase 
in invasive samples being sent for microbiology may 
assist in improving the rates of a positive diagnosis.
COMMENTS
Background
abdominal tuberculosis (aTB) accounts for 5% of all cases of tuberculosis 
(TB) in London. There is a high prevalence of TB in non-United Kingdom 
born population, in previous United Kingdom based studies this has been 
predominantly in patients of South asian origin. Positive confirmation of a 
diagnosis of aTB through culture of mycobacterium tuberculosis was achieved 
in 29 of 50 patients in a previous United Kingdom based series. Vitamin D 
Table 5  Breakdown of histology and microbiology according to route of specimen acquisition
n Cytology/histology sent Cytology/histology suggestive of tuberculosis Microbiology sent Culture + ve
Paracentesis 20 20 (100%)        7/9 (77.8%)
 had lymphocytic effusion1
19 (95%)  11/19 (57.9%)
Endoscopy 32  28 (87.5%) 14/28 (50%)    10 (31.3%) 3/10 (30%)
Surgery 16  15 (93.8%)    14/15 (93.3%)    13 (81.3%)    9/13 (69.2%)
1For ascitic fluid which was culture positive a lymphocyte count was not provided.
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replacement has been historically used in the treatment of TB, however vitamin 
D supplementation in the treatment of pulmonary TB (PTB) has not been shown 
to improve clinical outcomes.
Research frontiers
Vitamin D has emerged as an immune regulator, with associations between 
vitamin D deficiency and both inflammatory bowel disease and pulmonary TB, 
however benefits from supplementation in PTB are not clear, and its role in ATB 
has not yet been identified.
Innovations and breakthrough
This is the first United Kingdom based series which has identified patients of 
African origin with ATB. This is the first series of patients with ATB which has 
identified a prevalence of vitamin D deficiency.
Applications
This study confirms the difficulties in diagnosing patients with ATB despite a 
number of invasive investigations, and reinforces the importance of sending 
tissue for microbiological assessment. It suggests that all patients with aTB 
should be screened for PTB, human immunodeficiency virus and vitamin D 
deficiency.
Peer-review
This retrospective study, conducted with a large sample, is a valuable 
contribution to the literature on aTB. This is an interesting case series that is 
presented in a concise and balanced manner.
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